Michael V Templin

Title: Michael V Templin: Innovator in Therapeutics

Introduction

Michael V Templin is a notable inventor based in Bothell, WA (US), recognized for his contributions to the field of therapeutics. He holds 2 patents that focus on innovative compounds for regulating nucleic acid molecules in cells. His work has significant implications for therapeutic, diagnostic, and research applications.

Latest Patents

Templin's latest patents include "Therapeutics with conformationally restricted monomers" and "UNA oligomer structures for therapeutic agents." The first patent provides single-stranded and multi-stranded compounds that are useful in various therapeutic modalities. These compounds contain conformationally restricted nucleomonomers (CRN) and can also include hydroxymethyl substituted nucleomonomers (unlocked nucleomonomers, UNA). The second patent discloses double-stranded RNA complexes that incorporate hydroxymethyl substituted nucleomonomers in the passenger strand of an RNA complex. These RNA complexes are capable of modulating gene expression and have potential applications in therapeutics and diagnostics.

Career Highlights

Throughout his career, Templin has worked with prominent companies such as Marina Biotech, Inc. and Arcturus Therapeutics, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas in the field of biotechnology.

Collaborations

Templin has collaborated with notable professionals in his field, including Narendra Vaish and Michael E Houston, Jr. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Michael V Templin is a distinguished inventor whose work in therapeutics has the potential to impact various medical fields. His innovative patents and collaborations highlight his commitment to advancing biotechnology.